Press release
Anthrax - Pipeline Review, H1 2017
Anthrax is a serious infectious disease caused by Bacillus anthracis. Signs and symptoms include nausea, vomiting, abdominal pain, headache, loss of appetite, fever, severe, bloody diarrhea in the later stages of the disease, sore throat and difficulty swallowing. Risk factors include inject illegal drugs, handle animal skins and work in veterinary medicine, especially dealing with livestock.
Report Highlights
Publisher's Pharmaceutical and Healthcare latest pipeline guide Anthrax - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Anthrax (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Get Sample Copy of Report@ http://www.reportsweb.com/inquiry&RW0001689420/sample
The Anthrax (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Anthrax and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I, Preclinical and Discovery stages are 3, 5, 24 and 11 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 3 and 3 molecules, respectively.
Anthrax (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Find More Information@ http://www.reportsweb.com/anthrax-pipeline-review-h1-2017
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
List of Tables
Number of Products under Development for Anthrax, H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products under Development by Companies, H1 2017 (Contd..1), H1 2017
Number of Products under Development by Universities/Institutes, H1 2017
Products under Development by Companies, H1 2017
Products under Development by Companies, H1 2017 (Contd..1), H1 2017
Products under Development by Companies, H1 2017 (Contd..2), H1 2017
Products under Development by Universities/Institutes, H1 2017
Number of Products by Stage and Target, H1 2017
Number of Products by Stage and Mechanism of Action, H1 2017
Number of Products by Stage and Route of Administration, H1 2017
Number of Products by Stage and Molecule Type, H1 2017
Anthrax - Pipeline by Altimmune Inc, H1 2017
Anthrax - Pipeline by Aphios Corp, H1 2017
Anthrax - Pipeline by Aradigm Corp, H1 2017
Anthrax - Pipeline by AtralCipan, H1 2017
Anthrax - Pipeline by ContraFect Corp, H1 2017
Anthrax - Pipeline by Crestone Inc, H1 2017
Anthrax - Pipeline by Dynavax Technologies Corp, H1 2017
Anthrax - Pipeline by Emergent BioSolutions Inc, H1 2017
Anthrax - Pipeline by GlaxoSmithKline Plc, H1 2017
Anthrax - Pipeline by Green Cross Corp, H1 2017
Anthrax - Pipeline by Grifols SA, H1 2017
Anthrax - Pipeline by Hawaii Biotech Inc, H1 2017
Anthrax - Pipeline by iBio Inc, H1 2017
Anthrax - Pipeline by Merck & Co Inc, H1 2017
Anthrax - Pipeline by Microbiotix Inc, H1 2017
Anthrax - Pipeline by NanoBio Corp, H1 2017
Anthrax - Pipeline by Paratek Pharmaceuticals Inc, H1 2017
Anthrax - Pipeline by PaxVax Inc, H1 2017
Anthrax - Pipeline by Pfenex Inc, H1 2017
Anthrax - Pipeline by PharmAthene Inc, H1 2017
Anthrax - Pipeline by Planet Biotechnology Inc, H1 2017
Anthrax - Pipeline by Protein Potential LLC, H1 2017
Anthrax - Pipeline by ProThera Biologics Inc, H1 2017
Anthrax - Pipeline by Soligenix Inc, H1 2017
Anthrax - Pipeline by Syntiron LLC, H1 2017
Anthrax - Pipeline by Tetraphase Pharmaceuticals Inc, H1 2017
Anthrax - Pipeline by VLP Biotech Inc, H1 2017
Anthrax - Dormant Projects, H1 2017
Anthrax - Dormant Projects, H1 2017 (Contd..1), H1 2017
Anthrax - Dormant Projects, H1 2017 (Contd..2), H1 2017
Anthrax - Discontinued Products, H1 2017
Buy This Report@ http://www.reportsweb.com/buy&RW0001689420/buy/2000
List of Figures
Number of Products under Development for Anthrax, H1 2017
Number of Products under Development by Companies, H1 2017
Number of Products under Development by Universities/Institutes, H1 2017
Number of Products by Top 10 Targets, H1 2017
Number of Products by Stage and Top 10 Targets, H1 2017
Number of Products by Top 10 Mechanism of Actions, H1 2017
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
Number of Products by Routes of Administration, H1 2017
Number of Products by Stage and Routes of Administration, H1 2017
Number of Products by Top 10 Molecule Types, H1 2017
Number of Products by Stage and Top 10 Molecule Types, H1 2017
About ReportsWeb:
ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.
Contact Us:
Call: +1-646-491-9876
Email: sales@reportsweb.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anthrax - Pipeline Review, H1 2017 here
News-ID: 750548 • Views: …
More Releases from ReportsWeb
North America: Smart Airport Market Overall Study Report 2020-2026| Amadeus IT G …
The "Global North America Smart Airport Market: 2020" Industry Report is a professional and in-depth study on the current state of the North America Smart Airport Market by PMR. The North America Smart Airport market is supposed to demonstrate a considerable growth during the forecast period of 2020 - 2026. The company profiles of all the key players and brands that are dominating the market have been given in this…
Marine Biotechnology Market Future Forecast 2018-2026 by Leading Companies such …
ReportsWeb.com has announced the addition of the “Marine Biotechnology-Global Market Outlook 2017-2026” The report classifies the global Marine Biotechnology Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth.
According to Publisher, the Global Marine Biotechnology Market is accounted for $3.93 billion in 2017 and is expected to reach $8.74 billion by 2026 growing at a CAGR of 9.3% during…
Anti-Counterfeiting Packaging Market Growth Opportunities and Emerging Trends by …
ReportsWeb.com has announced the addition of the “Anti-Counterfeiting Packaging-Global Market Outlook 2017-2026” The report classifies the global Anti-Counterfeiting Packaging Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth.
According to Publisher, the Global Anti-Counterfeiting Packaging Market is accounted for $112.16 billion in 2017 and is expected to reach $427.96 billion by 2026 growing at a CAGR of 16.0% during…
Solar Photovoltaic in Italy Market Outlook to 2030 | Company Profiles (Tozzi Hol …
Solar Photovoltaic (PV) in Italy, Market Outlook to 2030, Update 2018-Capacity, Generation, Investment Trends, Regulations and Company Profiles
Summary
"Solar Photovoltaic (PV) in Italy, Market Outlook to 2030, Update 2018-Capacity, Generation, Investment Trends, Regulations and Company Profiles", is the latest report from Publisher, the industry analysis specialists that offer comprehensive information and understanding of the Solar Photovoltaic (PV) market in Italy.
The report provides in depth analysis on global renewable power market and…
More Releases for Anthrax
Anthrax Vaccines Market to Witness Robust Expansion by 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Anthrax Vaccines market.
Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against…
Anthrax Vaccine Market : A Complete Guide On Global Anthrax Vaccine Market And I …
Global Anthrax Vaccine Market
Precision Business Insights (PBI) in its report titled “Global Anthrax Vaccine Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2027” assesses the market performance over 2018-2027. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.
Anthrax is a bacterial infection caused by Bacillus…
Anthrax Vaccines Market Competitive Landscape Analysis with Forecast by 2025
Anthrax is a severe infectious disease caused by spores of a gram-positive bacterium called Bacillus anthracis. It generally infects through four routes viz. the lungs, the intestines, the skin, and injectable. Anthrax affects both humans and animals, especially ruminants such as cattle, sheep, goats, and horses. It does not easily spread from one person to another. Signs and symptoms of anthrax vary depending on the type of infection. Cutaneous anthrax,…
Anthrax Market Competitive Landscape Analysis with Forecast by 2025
Anthrax is a lethal disease affecting humans as well as animals such as goat, sheep, horses, and cattle. The causative agent is a gram positive, rod shaped bacterium Bacillus anthracis. Anthrax can spread through three main routes which include aerial route, digestive route and contact through skin. Common symptoms in human beings for respiratory infection include pneumonia and severe respiratory collapse. Gastrointestinal infection is associated with symptoms such as vomiting,…
Anthrax Vaccines Market 2017- Merial, Merck, Zoetis
Apex Research, recently published a detailed market research study focused on the "Anthrax Vaccines Market" across the global, regional and country level. The report provides 360° analysis of "Anthrax Vaccines Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Anthrax Vaccines industry, and estimates the future trend of Anthrax Vaccines market on…
Anthrax - Pipeline Assessment Considering Companies & Trends 2017
Market Research Hub latest Pharmaceutical and Healthcare disease pipeline guide “Anthrax Pipeline Review”, H2 2017, provides an overview of the Anthrax (Infectious Disease) pipeline landscape.
Anthrax is a serious infectious disease caused by Bacillus anthracis. Signs and symptoms include nausea, vomiting, abdominal pain, headache, loss of appetite, fever, severe, bloody diarrhea in the later stages of the disease, sore throat and difficulty swallowing. Risk factors include inject illegal drugs, handle animal…
